| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 3.19e-33 | 46 | 30 | 15 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 3.15e-23 | 188 | 30 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 4.08e-13 | 891 | 30 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 6.67e-07 | 12 | 30 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 1.87e-04 | 192 | 30 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 5.17e-04 | 105 | 30 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.61e-04 | 268 | 30 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.32e-03 | 323 | 30 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.63e-03 | 156 | 30 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | integrin binding | 2.26e-03 | 175 | 30 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.45e-03 | 180 | 30 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.66e-03 | 51 | 30 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.72e-03 | 187 | 30 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 3.34e-03 | 201 | 30 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | collagen binding | 6.57e-03 | 81 | 30 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 6.62e-03 | 257 | 30 | 3 | GO:0061134 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL5A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.08e-15 | 377 | 29 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL5A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.12e-15 | 378 | 29 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL5A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.15e-15 | 379 | 29 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.02e-11 | 76 | 29 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 3.75e-05 | 957 | 29 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.25e-04 | 12 | 29 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 1.33e-04 | 188 | 29 | 4 | GO:0007009 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.78e-04 | 228 | 29 | 4 | GO:0001101 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.88e-04 | 18 | 29 | 2 | GO:0038065 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 3.18e-31 | 88 | 30 | 16 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL3A1 COL4A4 COL4A5 COL5A1 COL5A3 COL7A1 COL11A2 COL28A1 COL1A1 | 1.98e-21 | 21 | 30 | 9 | GO:0098644 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 2.44e-18 | 530 | 30 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 5.72e-18 | 332 | 30 | 14 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 7.14e-17 | 656 | 30 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 7.50e-17 | 658 | 30 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.71e-15 | 12 | 30 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.71e-15 | 12 | 30 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type V trimer | 1.07e-08 | 4 | 30 | 3 | GO:0005588 | |
| GeneOntologyCellularComponent | basement membrane | 1.85e-08 | 122 | 30 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 COL4A4 COL4A5 COL5A1 COL5A3 COL6A3 COL11A2 CHMP4B COL28A1 COL1A1 | 3.55e-06 | 1187 | 30 | 10 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.99e-05 | 5 | 30 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.98e-05 | 6 | 30 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.55e-05 | 8 | 30 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.55e-05 | 8 | 30 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.55e-05 | 8 | 30 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.92e-04 | 1179 | 30 | 8 | GO:0099512 | |
| HumanPheno | Cigarette-paper scars | 1.13e-11 | 10 | 13 | 5 | HP:0001073 | |
| HumanPheno | Atrophic scars | 1.59e-10 | 37 | 13 | 6 | HP:0001075 | |
| HumanPheno | Atypical scarring of skin | 1.21e-08 | 74 | 13 | 6 | HP:0000987 | |
| HumanPheno | Cervical insufficiency | 5.19e-08 | 4 | 13 | 3 | HP:0030009 | |
| HumanPheno | Scarring | 8.52e-08 | 102 | 13 | 6 | HP:0100699 | |
| HumanPheno | Finger joint hypermobility | 1.10e-07 | 52 | 13 | 5 | HP:0006094 | |
| HumanPheno | Dermal atrophy | 1.14e-07 | 107 | 13 | 6 | HP:0004334 | |
| HumanPheno | Abnormality of hand joint mobility | 1.76e-07 | 57 | 13 | 5 | HP:0006256 | |
| HumanPheno | Molluscoid pseudotumors | 4.52e-07 | 7 | 13 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 4.52e-07 | 7 | 13 | 3 | HP:0000139 | |
| HumanPheno | Small joint hypermobilty | 4.66e-07 | 69 | 13 | 5 | HP:0430046 | |
| HumanPheno | Genital hernia | 7.22e-07 | 8 | 13 | 3 | HP:0100823 | |
| HumanPheno | Arterial rupture | 7.22e-07 | 8 | 13 | 3 | HP:0025019 | |
| HumanPheno | Fragile skin | 1.61e-06 | 37 | 13 | 4 | HP:0001030 | |
| HumanPheno | Subcutaneous nodule | 2.32e-06 | 95 | 13 | 5 | HP:0001482 | |
| HumanPheno | Arterial dissection | 2.82e-06 | 12 | 13 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 2.82e-06 | 12 | 13 | 3 | HP:0004947 | |
| HumanPheno | Abnormal uterine cervix morphology | 3.66e-06 | 13 | 13 | 3 | HP:0012888 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 4.77e-06 | 201 | 13 | 6 | HP:0008065 | |
| HumanPheno | Premature rupture of membranes | 8.65e-06 | 17 | 13 | 3 | HP:0001788 | |
| HumanPheno | Skin nodule | 1.18e-05 | 132 | 13 | 5 | HP:0200036 | |
| HumanPheno | Glomerular deposits | 1.44e-05 | 20 | 13 | 3 | HP:0030949 | |
| HumanPheno | Osteoarthritis | 1.58e-05 | 65 | 13 | 4 | HP:0002758 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.80e-05 | 3 | 13 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 1.80e-05 | 3 | 13 | 2 | HP:0011501 | |
| HumanPheno | Subcutaneous spheroids | 1.80e-05 | 3 | 13 | 2 | HP:0025014 | |
| HumanPheno | Reduced muscle collagen VI | 3.60e-05 | 4 | 13 | 2 | HP:0030095 | |
| HumanPheno | Piezogenic pedal papules | 3.60e-05 | 4 | 13 | 2 | HP:0025509 | |
| HumanPheno | Curved toe phalanx | 3.60e-05 | 4 | 13 | 2 | HP:0010176 | |
| HumanPheno | Reduced maximal expiratory pressure | 3.60e-05 | 4 | 13 | 2 | HP:0012497 | |
| HumanPheno | Incisional hernia | 3.60e-05 | 4 | 13 | 2 | HP:0004872 | |
| HumanPheno | Dermal translucency | 3.67e-05 | 27 | 13 | 3 | HP:0010648 | |
| HumanPheno | Increased laxity of fingers | 5.99e-05 | 5 | 13 | 2 | HP:0006149 | |
| HumanPheno | Bladder diverticulum | 8.83e-05 | 36 | 13 | 3 | HP:0000015 | |
| HumanPheno | Papule | 1.09e-04 | 209 | 13 | 5 | HP:0200034 | |
| HumanPheno | Wrist hypermobility | 1.25e-04 | 7 | 13 | 2 | HP:0005072 | |
| HumanPheno | Pulp calcification | 1.25e-04 | 7 | 13 | 2 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 1.25e-04 | 7 | 13 | 2 | HP:0006243 | |
| HumanPheno | Blepharochalasis | 1.67e-04 | 8 | 13 | 2 | HP:0010749 | |
| HumanPheno | Pulmonary artery aneurysm | 1.67e-04 | 8 | 13 | 2 | HP:0004937 | |
| HumanPheno | Neck flexor weakness | 1.85e-04 | 46 | 13 | 3 | HP:0003722 | |
| HumanPheno | Corneal erosion | 2.10e-04 | 48 | 13 | 3 | HP:0200020 | |
| HumanPheno | Lower-limb joint contracture | 2.51e-04 | 403 | 13 | 6 | HP:0005750 | |
| HumanPheno | Dilatation of the cerebral artery | 2.52e-04 | 51 | 13 | 3 | HP:0004944 | |
| HumanPheno | Lenticonus | 2.67e-04 | 10 | 13 | 2 | HP:0001142 | |
| HumanPheno | Premature osteoarthritis | 2.67e-04 | 10 | 13 | 2 | HP:0003088 | |
| HumanPheno | Joint laxity | 3.16e-04 | 55 | 13 | 3 | HP:0001388 | |
| HumanPheno | Hip dislocation | 3.23e-04 | 263 | 13 | 5 | HP:0002827 | |
| HumanPheno | Ecchymosis | 3.70e-04 | 58 | 13 | 3 | HP:0031364 | |
| HumanPheno | Thickened glomerular basement membrane | 3.91e-04 | 12 | 13 | 2 | HP:0004722 | |
| HumanPheno | Dermatochalasis | 3.91e-04 | 12 | 13 | 2 | HP:0010750 | |
| HumanPheno | Myopia | 4.44e-04 | 447 | 13 | 6 | HP:0000545 | |
| HumanPheno | Abnormality of the elbow | 4.47e-04 | 282 | 13 | 5 | HP:0009811 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 4.62e-04 | 13 | 13 | 2 | HP:0033282 | |
| HumanPheno | Abnormal uterus morphology | 5.12e-04 | 158 | 13 | 4 | HP:0031105 | |
| HumanPheno | Glomerular subepithelial deposits | 5.38e-04 | 14 | 13 | 2 | HP:0033603 | |
| HumanPheno | Tricuspid valve prolapse | 5.38e-04 | 14 | 13 | 2 | HP:0001704 | |
| HumanPheno | Soft, doughy skin | 5.38e-04 | 14 | 13 | 2 | HP:0001027 | |
| HumanPheno | Pulmonary artery dilatation | 5.38e-04 | 14 | 13 | 2 | HP:0004927 | |
| HumanPheno | Limb joint contracture | 5.77e-04 | 469 | 13 | 6 | HP:0003121 | |
| HumanPheno | Delayed ability to walk | 6.33e-04 | 304 | 13 | 5 | HP:0031936 | |
| HumanPheno | Aortic root aneurysm | 6.44e-04 | 70 | 13 | 3 | HP:0002616 | |
| HumanPheno | Delayed gross motor development | 6.61e-04 | 481 | 13 | 6 | HP:0002194 | |
| HumanPheno | Axial dystonia | 7.07e-04 | 16 | 13 | 2 | HP:0002530 | |
| HumanPheno | Lower extremity joint dislocation | 7.79e-04 | 318 | 13 | 5 | HP:0030311 | |
| HumanPheno | Abnormality of refraction | 7.85e-04 | 709 | 13 | 7 | HP:0000539 | |
| HumanPheno | Diaphragmatic weakness | 8.00e-04 | 17 | 13 | 2 | HP:0009113 | |
| HumanPheno | Abnormal scapula morphology | 8.57e-04 | 181 | 13 | 4 | HP:0000782 | |
| HumanPheno | Abnormality of lens shape | 8.99e-04 | 18 | 13 | 2 | HP:0011526 | |
| HumanPheno | Foot joint contracture | 9.76e-04 | 334 | 13 | 5 | HP:0008366 | |
| HumanPheno | Abnormality of the temporomandibular joint | 1.00e-03 | 19 | 13 | 2 | HP:0010754 | |
| HumanPheno | Abnormal cornea morphology | 1.06e-03 | 744 | 13 | 7 | HP:0000481 | |
| HumanPheno | Dilatation of the ascending aorta | 1.10e-03 | 84 | 13 | 3 | HP:0005111 | |
| HumanPheno | Congenital hip dislocation | 1.10e-03 | 84 | 13 | 3 | HP:0001374 | |
| HumanPheno | Shoulder dislocation | 1.11e-03 | 20 | 13 | 2 | HP:0003834 | |
| HumanPheno | Camptodactyly | 1.15e-03 | 346 | 13 | 5 | HP:0012385 | |
| HumanPheno | Generalized amyotrophy | 1.18e-03 | 86 | 13 | 3 | HP:0003700 | |
| HumanPheno | Torticollis | 1.22e-03 | 87 | 13 | 3 | HP:0000473 | |
| HumanPheno | Oromandibular dystonia | 1.23e-03 | 21 | 13 | 2 | HP:0012048 | |
| HumanPheno | Macular purpura | 1.30e-03 | 89 | 13 | 3 | HP:0031365 | |
| HumanPheno | Thin skin | 1.34e-03 | 90 | 13 | 3 | HP:0000963 | |
| HumanPheno | Vitreoretinopathy | 1.35e-03 | 22 | 13 | 2 | HP:0007773 | |
| HumanPheno | Flexion contracture of digit | 1.41e-03 | 362 | 13 | 5 | HP:0030044 | |
| HumanPheno | Upper-limb joint contracture | 1.41e-03 | 362 | 13 | 5 | HP:0100360 | |
| HumanPheno | Joint hypermobility | 1.45e-03 | 557 | 13 | 6 | HP:0001382 | |
| HumanPheno | Quadriceps muscle weakness | 1.48e-03 | 23 | 13 | 2 | HP:0003731 | |
| HumanPheno | Neck muscle weakness | 1.57e-03 | 95 | 13 | 3 | HP:0000467 | |
| HumanPheno | Abnormal joint physiology | COL3A1 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL11A2 FUS COL1A1 | 1.61e-03 | 1358 | 13 | 9 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL3A1 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL11A2 FUS COL1A1 | 1.61e-03 | 1358 | 13 | 9 | HP:0011729 |
| HumanPheno | Lumbar hyperlordosis | 1.77e-03 | 99 | 13 | 3 | HP:0002938 | |
| HumanPheno | Flexion contracture | 1.87e-03 | 817 | 13 | 7 | HP:0001371 | |
| HumanPheno | Joint dislocation | 1.97e-03 | 390 | 13 | 5 | HP:0001373 | |
| HumanPheno | Progressive proximal muscle weakness | 2.04e-03 | 27 | 13 | 2 | HP:0009073 | |
| HumanPheno | Abnormal lens morphology | 2.17e-03 | 837 | 13 | 7 | HP:0000517 | |
| HumanPheno | Joint contracture | 2.27e-03 | 843 | 13 | 7 | HP:0034392 | |
| HumanPheno | Arteriovenous malformation | 2.27e-03 | 108 | 13 | 3 | HP:0100026 | |
| HumanPheno | Blue sclerae | 2.27e-03 | 108 | 13 | 3 | HP:0000592 | |
| HumanPheno | Pain | 2.31e-03 | 846 | 13 | 7 | HP:0012531 | |
| HumanPheno | Flexion contracture of finger | 2.45e-03 | 240 | 13 | 4 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 2.45e-03 | 240 | 13 | 4 | HP:0010563 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 1.82e-05 | 27 | 27 | 3 | MP:0008438 | |
| MousePheno | renal glomerular synechia | 3.58e-05 | 5 | 27 | 2 | MP:0011483 | |
| MousePheno | abnormal dermal layer morphology | 5.16e-05 | 108 | 27 | 4 | MP:0001243 | |
| MousePheno | podocyte foot process effacement | 5.18e-05 | 38 | 27 | 3 | MP:0008140 | |
| MousePheno | abnormal tendon collagen fibril morphology | 7.50e-05 | 7 | 27 | 2 | MP:0011643 | |
| MousePheno | expanded mesangial matrix | 9.23e-05 | 46 | 27 | 3 | MP:0011353 | |
| MousePheno | abnormal mesangial matrix morphology | 1.26e-04 | 51 | 27 | 3 | MP:0011338 | |
| MousePheno | aortic dissection | 1.28e-04 | 9 | 27 | 2 | MP:0004044 | |
| MousePheno | abnormal podocyte foot process morphology | 1.58e-04 | 55 | 27 | 3 | MP:0008059 | |
| MousePheno | abnormal podocyte morphology | 3.23e-04 | 70 | 27 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 3.23e-04 | 70 | 27 | 3 | MP:0011497 | |
| MousePheno | abnormal glomerular mesangium morphology | 5.33e-04 | 83 | 27 | 3 | MP:0011339 | |
| MousePheno | hematuria | 6.02e-04 | 19 | 27 | 2 | MP:0005161 | |
| Domain | Collagen | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 4.90e-31 | 85 | 29 | 16 | PF01391 |
| Domain | Collagen | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 4.90e-31 | 85 | 29 | 16 | IPR008160 |
| Domain | TSPN | 8.00e-13 | 23 | 29 | 6 | SM00210 | |
| Domain | Fib_collagen_C | 2.88e-12 | 11 | 29 | 5 | IPR000885 | |
| Domain | NC1_FIB | 2.88e-12 | 11 | 29 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 2.88e-12 | 11 | 29 | 5 | PD002078 | |
| Domain | COLFI | 2.88e-12 | 11 | 29 | 5 | SM00038 | |
| Domain | COLFI | 2.88e-12 | 11 | 29 | 5 | PF01410 | |
| Domain | Laminin_G | 3.09e-10 | 58 | 29 | 6 | IPR001791 | |
| Domain | VWA | 2.27e-08 | 56 | 29 | 5 | PF00092 | |
| Domain | - | 9.39e-08 | 74 | 29 | 5 | 3.40.50.410 | |
| Domain | VWFA | 1.58e-07 | 82 | 29 | 5 | PS50234 | |
| Domain | VWA | 1.78e-07 | 84 | 29 | 5 | SM00327 | |
| Domain | VWF_A | 4.06e-07 | 99 | 29 | 5 | IPR002035 | |
| Domain | LamG | 6.09e-07 | 44 | 29 | 4 | SM00282 | |
| Domain | ConA-like_dom | 9.20e-07 | 219 | 29 | 6 | IPR013320 | |
| Domain | - | 2.70e-06 | 18 | 29 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.70e-06 | 18 | 29 | 3 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 3.21e-06 | 19 | 29 | 3 | PS50279 | |
| Domain | BPTI_KUNITZ_1 | 3.21e-06 | 19 | 29 | 3 | PS00280 | |
| Domain | Kunitz_BPTI | 3.21e-06 | 19 | 29 | 3 | PF00014 | |
| Domain | Kunitz_BPTI | 5.84e-06 | 23 | 29 | 3 | IPR002223 | |
| Domain | - | 1.35e-05 | 95 | 29 | 4 | 2.60.120.200 | |
| Domain | CTDL_fold | 2.17e-05 | 107 | 29 | 4 | IPR016187 | |
| Domain | Laminin_G_2 | 3.20e-05 | 40 | 29 | 3 | PF02210 | |
| Domain | C4 | 3.48e-05 | 6 | 29 | 2 | SM00111 | |
| Domain | - | 3.48e-05 | 6 | 29 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 3.48e-05 | 6 | 29 | 2 | IPR001442 | |
| Domain | NC1_IV | 3.48e-05 | 6 | 29 | 2 | PS51403 | |
| Domain | C4 | 3.48e-05 | 6 | 29 | 2 | PF01413 | |
| Domain | KU | 3.51e-04 | 18 | 29 | 2 | SM00131 | |
| Domain | VWC | 8.58e-04 | 28 | 29 | 2 | PF00093 | |
| Domain | VWFC_1 | 1.42e-03 | 36 | 29 | 2 | PS01208 | |
| Domain | VWC | 1.58e-03 | 38 | 29 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.58e-03 | 38 | 29 | 2 | PS50184 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 29 | 2 | IPR001007 | |
| Domain | - | 9.89e-03 | 97 | 29 | 2 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 1.03e-02 | 99 | 29 | 2 | IPR016186 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 2.03e-31 | 41 | 23 | 14 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 6.61e-31 | 44 | 23 | 14 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.28e-28 | 61 | 23 | 14 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 5.55e-28 | 67 | 23 | 14 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 3.88e-27 | 76 | 23 | 14 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 5.06e-26 | 90 | 23 | 14 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL16A1 COL1A1 | 3.34e-23 | 64 | 23 | 12 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL1A1 | 4.49e-22 | 50 | 23 | 11 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL1A1 | 9.15e-22 | 53 | 23 | 11 | MM14566 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL1A1 | 4.99e-21 | 61 | 23 | 11 | M27103 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL3A1 COL4A4 COL4A5 COL5A1 COL6A2 COL6A3 COL7A1 COL11A2 COL16A1 COL1A1 | 5.31e-20 | 46 | 23 | 10 | M198 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL16A1 COL1A1 | 6.75e-20 | 76 | 23 | 11 | MM14867 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 2.35e-19 | 258 | 23 | 14 | MM14572 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL16A1 COL1A1 | 2.50e-19 | 85 | 23 | 11 | M16441 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL16A1 COL1A1 | 7.02e-19 | 140 | 23 | 12 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.99e-18 | 300 | 23 | 14 | M610 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL11A2 COL1A1 | 2.70e-18 | 66 | 23 | 10 | M18 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL1A1 | 7.36e-18 | 114 | 23 | 11 | MM14571 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL3A1 COL4A4 COL4A5 COL5A1 COL6A2 COL6A3 COL7A1 COL11A2 COL16A1 COL1A1 | 9.15e-18 | 74 | 23 | 10 | M160 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.56e-16 | 20 | 23 | 7 | MM15061 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.67e-14 | 32 | 23 | 7 | MM14924 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.37e-13 | 38 | 23 | 7 | MM14969 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.25e-13 | 76 | 23 | 8 | M27219 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.91e-13 | 42 | 23 | 7 | M7169 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.15e-13 | 84 | 23 | 8 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.81e-12 | 57 | 23 | 7 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.20e-12 | 58 | 23 | 7 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.62e-12 | 59 | 23 | 7 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.85e-12 | 63 | 23 | 7 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.31e-11 | 19 | 23 | 5 | MM15512 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.54e-11 | 47 | 23 | 6 | MM14925 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.60e-10 | 199 | 23 | 8 | M7253 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.01e-09 | 30 | 23 | 5 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.01e-09 | 30 | 23 | 5 | MM15517 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.23e-09 | 41 | 23 | 5 | M27778 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.71e-09 | 43 | 23 | 5 | M39565 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 7.26e-09 | 15 | 23 | 4 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A3 COL11A2 COL1A1 | 9.19e-09 | 418 | 23 | 9 | MM15587 |
| Pathway | WP_FOCAL_ADHESION | 1.32e-08 | 187 | 23 | 7 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.56e-08 | 67 | 23 | 5 | MM15345 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A3 COL11A2 COL1A1 | 7.39e-08 | 532 | 23 | 9 | M27870 |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 9.22e-08 | 27 | 23 | 4 | M27217 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.31e-07 | 261 | 23 | 7 | MM15676 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.43e-07 | 30 | 23 | 4 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.51e-07 | 79 | 23 | 5 | M27643 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.53e-07 | 302 | 23 | 7 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 5.91e-07 | 326 | 23 | 7 | MM15917 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.05e-06 | 18 | 23 | 3 | M27164 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 3.05e-06 | 18 | 23 | 3 | M39421 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.05e-06 | 18 | 23 | 3 | MM14882 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.61e-06 | 19 | 23 | 3 | M27221 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.04e-05 | 502 | 23 | 7 | MM14537 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.21e-05 | 28 | 23 | 3 | MM15957 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.51e-05 | 575 | 23 | 7 | M29853 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.49e-05 | 43 | 23 | 3 | M53 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-04 | 10 | 23 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-04 | 10 | 23 | 2 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.39e-04 | 11 | 23 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.66e-04 | 12 | 23 | 2 | MM1526 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.84e-04 | 339 | 23 | 5 | M39736 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.96e-04 | 13 | 23 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.96e-04 | 13 | 23 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.29e-04 | 14 | 23 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.29e-04 | 14 | 23 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.64e-04 | 15 | 23 | 2 | MM14922 | |
| Pathway | WP_FOCAL_ADHESION | 2.76e-04 | 199 | 23 | 4 | M39402 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 4.75e-04 | 20 | 23 | 2 | M15394 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 5.22e-04 | 98 | 23 | 3 | M27152 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.31e-04 | 23 | 23 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.31e-04 | 23 | 23 | 2 | MM1427 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.08e-03 | 30 | 23 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.08e-03 | 30 | 23 | 2 | M39641 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.35e-03 | 1432 | 23 | 8 | M509 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.91e-03 | 40 | 23 | 2 | MM15000 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.31e-03 | 44 | 23 | 2 | M27295 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 2.42e-03 | 45 | 23 | 2 | M39864 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.97e-03 | 50 | 23 | 2 | M48087 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.50e-03 | 190 | 23 | 3 | M8240 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 4.83e-03 | 64 | 23 | 2 | M200 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 5.51e-03 | 725 | 23 | 5 | M27507 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 5.59e-03 | 69 | 23 | 2 | M48052 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.07e-03 | 72 | 23 | 2 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.24e-03 | 73 | 23 | 2 | MM15906 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.06e-02 | 96 | 23 | 2 | M39834 | |
| Pubmed | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 5.32e-25 | 175 | 30 | 14 | 28071719 | |
| Pubmed | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL16A1 COL28A1 COL1A1 | 5.00e-23 | 167 | 30 | 13 | 22159717 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL11A2 COL16A1 COL28A1 COL1A1 | 5.78e-22 | 135 | 30 | 12 | 28675934 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL3A1 COL4A5 COL5A1 COL6A2 COL5A3 COL7A1 COL11A2 COL16A1 COL1A1 | 1.38e-18 | 62 | 30 | 9 | 28344315 |
| Pubmed | COL3A1 COL4A4 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL16A1 COL28A1 COL1A1 | 5.61e-17 | 153 | 30 | 10 | 25037231 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.52e-14 | 97 | 30 | 8 | 27559042 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 15365990 | ||
| Pubmed | 3.74e-12 | 50 | 30 | 6 | 23658023 | ||
| Pubmed | 1.75e-11 | 64 | 30 | 6 | 22261194 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.14e-11 | 8 | 30 | 4 | 20059976 | |
| Pubmed | 3.73e-11 | 146 | 30 | 7 | 27068509 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 9.41e-11 | 10 | 30 | 4 | 15345741 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.08e-10 | 86 | 30 | 6 | 28327460 | |
| Pubmed | 1.65e-10 | 38 | 30 | 5 | 25572963 | ||
| Pubmed | 1.90e-10 | 39 | 30 | 5 | 33580754 | ||
| Pubmed | 4.79e-10 | 210 | 30 | 7 | 16537572 | ||
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 5.79e-10 | 3 | 30 | 3 | 17453912 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 8806434 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 23624467 | ||
| Pubmed | 4.72e-09 | 24 | 30 | 4 | 25344368 | ||
| Pubmed | 5.62e-09 | 25 | 30 | 4 | 19180518 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 5.78e-09 | 5 | 30 | 3 | 14758483 | |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 10995453 | ||
| Pubmed | 1.05e-08 | 29 | 30 | 4 | 22613833 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 21467034 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 10722718 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.16e-08 | 6 | 30 | 3 | 17029294 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 9101290 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.16e-08 | 6 | 30 | 3 | 8563024 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.16e-08 | 6 | 30 | 3 | 3571333 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.51e-08 | 101 | 30 | 5 | 20551380 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 3.23e-08 | 8 | 30 | 3 | 33875569 | |
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 18816857 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 3.23e-08 | 8 | 30 | 3 | 12766770 | |
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 9878537 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 8900172 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 2446864 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 14559231 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 20864640 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 9415455 | ||
| Pubmed | 9.51e-08 | 11 | 30 | 3 | 15121863 | ||
| Pubmed | 9.51e-08 | 11 | 30 | 3 | 2745554 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.27e-07 | 12 | 30 | 3 | 12180907 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 1.65e-07 | 13 | 30 | 3 | 21173153 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 1.65e-07 | 13 | 30 | 3 | 36335435 | |
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 2.09e-07 | 14 | 30 | 3 | 20858856 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 2.62e-07 | 15 | 30 | 3 | 9832566 | |
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 17881772 | ||
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 22573622 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 3.91e-07 | 17 | 30 | 3 | 10213384 | |
| Pubmed | 5.30e-07 | 186 | 30 | 5 | 20452482 | ||
| Pubmed | 5.30e-07 | 186 | 30 | 5 | 20673868 | ||
| Pubmed | 5.56e-07 | 19 | 30 | 3 | 29196262 | ||
| Pubmed | 5.56e-07 | 19 | 30 | 3 | 15689378 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.46e-07 | 79 | 30 | 4 | 18757743 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34356072 | ||
| Pubmed | Type V collagen controls the initiation of collagen fibril assembly. | 7.19e-07 | 2 | 30 | 2 | 15383546 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27363273 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27636223 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18401458 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28632965 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20015075 | ||
| Pubmed | Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis. | 7.19e-07 | 2 | 30 | 2 | 34261485 | |
| Pubmed | Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle. | 7.19e-07 | 2 | 30 | 2 | 21215393 | |
| Pubmed | Collagen I and collagen III polymorphisms in women with pelvic organ prolapse. | 7.19e-07 | 2 | 30 | 2 | 32692893 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35587586 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9195222 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16521042 | ||
| Pubmed | Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. | 7.19e-07 | 2 | 30 | 2 | 19560165 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31892712 | ||
| Pubmed | Collagen synthesis is not altered in women with stress urinary incontinence. | 7.19e-07 | 2 | 30 | 2 | 15227656 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31239369 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14970208 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26910848 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15095409 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23040566 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38102224 | ||
| Pubmed | RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts. | 7.19e-07 | 2 | 30 | 2 | 17576241 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23344861 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9099729 | ||
| Pubmed | CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen. | 7.19e-07 | 2 | 30 | 2 | 23517059 | |
| Pubmed | Altered procollagen gene expression in mid-gestational mouse excisional wounds. | 7.19e-07 | 2 | 30 | 2 | 17950069 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23377784 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25432063 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33409715 | ||
| Pubmed | DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner. | 7.19e-07 | 2 | 30 | 2 | 34061233 | |
| Pubmed | 7.62e-07 | 21 | 30 | 3 | 27856617 | ||
| Pubmed | 8.82e-07 | 22 | 30 | 3 | 27527664 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 2.16e-06 | 3 | 30 | 2 | 25204870 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.16e-06 | 3 | 30 | 2 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 2.16e-06 | 3 | 30 | 2 | 15954103 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 36130833 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26406420 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 14507670 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 6501291 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 33819468 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 2.16e-06 | 3 | 30 | 2 | 38433557 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15908193 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7780011 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 2.16e-06 | 3 | 30 | 2 | 27859054 | |
| Interaction | LAIR2 interactions | 3.76e-15 | 49 | 30 | 8 | int:LAIR2 | |
| Interaction | MMP9 interactions | 6.23e-12 | 67 | 30 | 7 | int:MMP9 | |
| Interaction | MMP2 interactions | 4.10e-11 | 87 | 30 | 7 | int:MMP2 | |
| Interaction | COL8A2 interactions | 4.21e-09 | 42 | 30 | 5 | int:COL8A2 | |
| Interaction | C1QTNF1 interactions | 7.56e-09 | 47 | 30 | 5 | int:C1QTNF1 | |
| Interaction | PLOD1 interactions | 7.83e-09 | 292 | 30 | 8 | int:PLOD1 | |
| Interaction | COLGALT2 interactions | 4.66e-08 | 67 | 30 | 5 | int:COLGALT2 | |
| Interaction | COL1A2 interactions | 1.01e-07 | 78 | 30 | 5 | int:COL1A2 | |
| Interaction | DCN interactions | 4.73e-07 | 43 | 30 | 4 | int:DCN | |
| Interaction | THBS1 interactions | 1.15e-06 | 127 | 30 | 5 | int:THBS1 | |
| Interaction | SPARC interactions | 2.54e-06 | 65 | 30 | 4 | int:SPARC | |
| Interaction | MAG interactions | 1.06e-05 | 29 | 30 | 3 | int:MAG | |
| Interaction | PDGFA interactions | 1.43e-05 | 32 | 30 | 3 | int:PDGFA | |
| Interaction | C1QC interactions | 3.29e-05 | 42 | 30 | 3 | int:C1QC | |
| Interaction | CD93 interactions | 4.05e-05 | 45 | 30 | 3 | int:CD93 | |
| Interaction | COL5A3 interactions | 9.57e-05 | 10 | 30 | 2 | int:COL5A3 | |
| Interaction | MEN1 interactions | 9.62e-05 | 1029 | 30 | 8 | int:MEN1 | |
| Interaction | C1QTNF2 interactions | 1.06e-04 | 62 | 30 | 3 | int:C1QTNF2 | |
| Interaction | COL5A1 interactions | 1.22e-04 | 65 | 30 | 3 | int:COL5A1 | |
| Interaction | FBLN2 interactions | 1.28e-04 | 66 | 30 | 3 | int:FBLN2 | |
| Interaction | LAMA1 interactions | 1.28e-04 | 66 | 30 | 3 | int:LAMA1 | |
| Interaction | FN1 interactions | 1.98e-04 | 848 | 30 | 7 | int:FN1 | |
| Interaction | FGF7 interactions | 2.54e-04 | 16 | 30 | 2 | int:FGF7 | |
| Interaction | PDGFB interactions | 3.00e-04 | 88 | 30 | 3 | int:PDGFB | |
| Interaction | SUPT5H interactions | 3.12e-04 | 408 | 30 | 5 | int:SUPT5H | |
| Interaction | HABP2 interactions | 3.23e-04 | 18 | 30 | 2 | int:HABP2 | |
| Interaction | COL16A1 interactions | 3.23e-04 | 18 | 30 | 2 | int:COL16A1 | |
| Interaction | DEFB125 interactions | 4.00e-04 | 20 | 30 | 2 | int:DEFB125 | |
| Interaction | OSM interactions | 4.00e-04 | 20 | 30 | 2 | int:OSM | |
| Interaction | COL18A1 interactions | 4.12e-04 | 98 | 30 | 3 | int:COL18A1 | |
| Interaction | PRPF40A interactions | 4.68e-04 | 446 | 30 | 5 | int:PRPF40A | |
| Interaction | BMP1 interactions | 5.92e-04 | 111 | 30 | 3 | int:BMP1 | |
| Interaction | HNRNPM interactions | 5.93e-04 | 723 | 30 | 6 | int:HNRNPM | |
| Interaction | MATN2 interactions | 6.24e-04 | 113 | 30 | 3 | int:MATN2 | |
| Interaction | COL7A1 interactions | 6.29e-04 | 25 | 30 | 2 | int:COL7A1 | |
| Interaction | TGFBI interactions | 6.29e-04 | 25 | 30 | 2 | int:TGFBI | |
| Cytoband | 17q25.3 | 2.00e-03 | 101 | 30 | 2 | 17q25.3 | |
| Cytoband | 21q22.3 | 3.19e-03 | 128 | 30 | 2 | 21q22.3 | |
| GeneFamily | Collagens | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 4.99e-31 | 46 | 26 | 14 | 490 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.36e-32 | 43 | 30 | 14 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.99e-32 | 44 | 30 | 14 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.43e-22 | 270 | 30 | 15 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A4 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.89e-22 | 275 | 30 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 1.79e-15 | 1008 | 30 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A4 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 OTOL1 COL22A1 COL11A2 COL16A1 COL28A1 COL1A1 | 2.35e-15 | 1026 | 30 | 16 | M5889 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 6.15e-13 | 29 | 30 | 6 | MM17055 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 5.06e-11 | 200 | 30 | 8 | M5930 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.80e-10 | 71 | 30 | 6 | M3955 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.85e-10 | 40 | 30 | 5 | M5887 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL1A1 | 3.40e-09 | 505 | 30 | 9 | M39167 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.01e-08 | 64 | 30 | 5 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.09e-08 | 65 | 30 | 5 | M39309 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.22e-08 | 23 | 30 | 4 | M48001 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.50e-08 | 261 | 30 | 7 | M1834 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.83e-08 | 72 | 30 | 5 | M9908 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.26e-08 | 75 | 30 | 5 | MM1084 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.70e-08 | 6 | 30 | 3 | M48000 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.94e-08 | 79 | 30 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.13e-08 | 80 | 30 | 5 | MM1285 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 6.01e-08 | 91 | 30 | 5 | M40180 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 7.12e-08 | 35 | 30 | 4 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.12e-08 | 35 | 30 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.00e-08 | 36 | 30 | 4 | MM1212 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 9.18e-08 | 99 | 30 | 5 | M39152 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.16e-07 | 352 | 30 | 7 | M17471 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL5A1 COL6A2 COL5A3 COL6A3 COL7A1 COL16A1 COL28A1 COL1A1 | 1.24e-07 | 767 | 30 | 9 | M39209 |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.60e-07 | 369 | 30 | 7 | MM16610 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.12e-07 | 117 | 30 | 5 | M39300 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 2.40e-07 | 120 | 30 | 5 | M42505 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 5.22e-07 | 268 | 30 | 6 | M45796 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 5.95e-07 | 144 | 30 | 5 | M1484 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 6.82e-07 | 148 | 30 | 5 | MM1010 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 7.03e-07 | 681 | 30 | 8 | M39175 | |
| Coexpression | DEMAGALHAES_AGING_DN | 7.50e-07 | 16 | 30 | 3 | M2145 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 7.53e-07 | 151 | 30 | 5 | M8901 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 9.10e-07 | 17 | 30 | 3 | M47995 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 9.13e-07 | 157 | 30 | 5 | MM1099 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 1.09e-06 | 18 | 30 | 3 | M47984 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.14e-06 | 69 | 30 | 4 | M10165 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.41e-06 | 318 | 30 | 6 | M41707 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.52e-06 | 74 | 30 | 4 | M13547 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.98e-06 | 337 | 30 | 6 | MM16606 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 2.46e-06 | 192 | 30 | 5 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.59e-06 | 194 | 30 | 5 | M39122 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.04e-06 | 88 | 30 | 4 | M1167 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 3.88e-06 | 27 | 30 | 3 | M47994 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 3.95e-06 | 380 | 30 | 6 | M41703 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 4.26e-06 | 385 | 30 | 6 | M39264 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 5.06e-06 | 100 | 30 | 4 | MM514 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 5.81e-06 | 229 | 30 | 5 | MM16607 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 7.21e-06 | 33 | 30 | 3 | M9167 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.02e-05 | 257 | 30 | 5 | M13867 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.13e-05 | 457 | 30 | 6 | M1613 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 1.22e-05 | 267 | 30 | 5 | M6100 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.27e-05 | 126 | 30 | 4 | M39132 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.33e-05 | 470 | 30 | 6 | MM1053 | |
| Coexpression | RB_P107_DN.V1_UP | 1.43e-05 | 130 | 30 | 4 | M2802 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.76e-05 | 137 | 30 | 4 | M40313 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 2.01e-05 | 296 | 30 | 5 | M41675 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 2.14e-05 | 300 | 30 | 5 | M41708 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 2.26e-05 | 48 | 30 | 3 | M39318 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 2.51e-05 | 310 | 30 | 5 | MM16608 | |
| Coexpression | DESCARTES_FETAL_STOMACH_STROMAL_CELLS | 2.56e-05 | 50 | 30 | 3 | M40304 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 2.56e-05 | 50 | 30 | 3 | MM403 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 2.75e-05 | 316 | 30 | 5 | M2293 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 2.93e-05 | 156 | 30 | 4 | M40151 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.05e-05 | 323 | 30 | 5 | MM1066 | |
| Coexpression | MA_RAT_AGING_DN | 3.32e-05 | 161 | 30 | 4 | M46419 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 3.41e-05 | 55 | 30 | 3 | MM3666 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 3.73e-05 | 337 | 30 | 5 | M13206 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN | 4.10e-05 | 170 | 30 | 4 | M8689 | |
| Coexpression | MA_RAT_AGING_DN | 4.10e-05 | 170 | 30 | 4 | MM16097 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 4.21e-05 | 59 | 30 | 3 | M47993 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 5.02e-05 | 179 | 30 | 4 | M41745 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 5.63e-05 | 65 | 30 | 3 | M41673 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 5.72e-05 | 610 | 30 | 6 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 5.98e-05 | 615 | 30 | 6 | M8673 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.45e-05 | 68 | 30 | 3 | M1373 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 6.92e-05 | 11 | 30 | 2 | M47997 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | 7.37e-05 | 389 | 30 | 5 | M4995 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.65e-05 | 72 | 30 | 3 | MM1131 | |
| Coexpression | HALLMARK_MYOGENESIS | 7.72e-05 | 200 | 30 | 4 | M5909 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 8.12e-05 | 650 | 30 | 6 | MM1042 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 8.20e-05 | 398 | 30 | 5 | M7514 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 8.76e-05 | 659 | 30 | 6 | MM1040 | |
| Coexpression | PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP | 9.35e-05 | 77 | 30 | 3 | M2364 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 1.07e-04 | 421 | 30 | 5 | MM985 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.09e-04 | 81 | 30 | 3 | M39253 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 1.13e-04 | 82 | 30 | 3 | M39274 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 1.17e-04 | 83 | 30 | 3 | M14650 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.17e-04 | 83 | 30 | 3 | M2448 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 1.20e-04 | 224 | 30 | 4 | M9893 | |
| Coexpression | ZHU_CMV_24_HR_DN | 1.21e-04 | 84 | 30 | 3 | M4065 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.30e-04 | 86 | 30 | 3 | M2259 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 1.32e-04 | 15 | 30 | 2 | M9138 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.44e-04 | 89 | 30 | 3 | M48353 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 1.50e-04 | 16 | 30 | 2 | M5718 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | 1.51e-04 | 1054 | 30 | 7 | M45798 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 1.51e-04 | 238 | 30 | 4 | M12004 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.79e-08 | 66 | 29 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.76e-07 | 95 | 29 | 5 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.95e-07 | 97 | 29 | 5 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.69e-07 | 229 | 29 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.17e-06 | 139 | 29 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 1.79e-06 | 65 | 29 | 4 | BM Top 100 - myometrium | |
| CoexpressionAtlas | BM Top 100 - cervix | 1.91e-06 | 66 | 29 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 2.15e-06 | 68 | 29 | 4 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 2.28e-06 | 69 | 29 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - ovary | 2.42e-06 | 70 | 29 | 4 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 2.42e-06 | 70 | 29 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 2.56e-06 | 71 | 29 | 4 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 2.71e-06 | 72 | 29 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.80e-06 | 166 | 29 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 2.86e-06 | 73 | 29 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 3.02e-06 | 74 | 29 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 3.02e-06 | 74 | 29 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - urethra | 3.54e-06 | 77 | 29 | 4 | BM Top 100 - urethra | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_100 | 4.56e-06 | 82 | 29 | 4 | gudmap_developingGonad_P2_epididymis_100 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 5.02e-06 | 84 | 29 | 4 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 6.04e-06 | 88 | 29 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.47e-06 | 197 | 29 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 7.11e-06 | 783 | 29 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 8.04e-06 | 206 | 29 | 5 | JC_fibro_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 8.24e-06 | 799 | 29 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 9.65e-06 | 99 | 29 | 4 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 1.81e-05 | 116 | 29 | 4 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 1.87e-05 | 117 | 29 | 4 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.33e-05 | 437 | 29 | 6 | GSM777046_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.27e-05 | 464 | 29 | 6 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.59e-05 | 281 | 29 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.59e-05 | 281 | 29 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 3.88e-05 | 990 | 29 | 8 | JC_fibro_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.00e-05 | 142 | 29 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k2 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 4.11e-05 | 143 | 29 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 4.58e-05 | 493 | 29 | 6 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 4.90e-05 | 300 | 29 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 5.78e-05 | 761 | 29 | 7 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200 | 5.91e-05 | 157 | 29 | 4 | gudmap_developingGonad_P2_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 7.32e-05 | 790 | 29 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 7.74e-05 | 797 | 29 | 7 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.84e-05 | 814 | 29 | 7 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_100 | 9.83e-05 | 11 | 29 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k5 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.89e-05 | 66 | 29 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 1.18e-04 | 70 | 29 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 1.28e-04 | 72 | 29 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.30e-04 | 369 | 29 | 5 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.33e-04 | 371 | 29 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | BM Top 100 - vagina | 1.51e-04 | 76 | 29 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 1.57e-04 | 77 | 29 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_500 | 1.62e-04 | 387 | 29 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.78e-04 | 395 | 29 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_100 | 1.87e-04 | 15 | 29 | 2 | gudmap_developingGonad_P2_epididymis_100_k1 | |
| CoexpressionAtlas | BM Top 100 - vulva | 1.89e-04 | 82 | 29 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-04 | 214 | 29 | 4 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100 | 1.96e-04 | 83 | 29 | 3 | gudmap_developingGonad_e18.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.98e-04 | 404 | 29 | 5 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.03e-04 | 406 | 29 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.10e-04 | 85 | 29 | 3 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.25e-04 | 87 | 29 | 3 | GSM777050_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.32e-04 | 951 | 29 | 7 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 2.65e-04 | 92 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.75e-04 | 234 | 29 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.10e-04 | 97 | 29 | 3 | GSM777046_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.10e-04 | 445 | 29 | 5 | GSM777043_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 3.19e-04 | 98 | 29 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.22e-04 | 244 | 29 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.39e-04 | 100 | 29 | 3 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.39e-04 | 100 | 29 | 3 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.43e-04 | 455 | 29 | 5 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 3.48e-04 | 249 | 29 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.83e-04 | 466 | 29 | 5 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.41e-04 | 265 | 29 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 4.77e-04 | 489 | 29 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 4.77e-04 | 489 | 29 | 5 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 5.00e-04 | 494 | 29 | 5 | JC_fibro_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 5.09e-04 | 496 | 29 | 5 | Arv_EB-LF_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.13e-04 | 276 | 29 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 5.18e-04 | 498 | 29 | 5 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 5.42e-04 | 280 | 29 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.43e-04 | 1094 | 29 | 7 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 5.50e-04 | 118 | 29 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 5.72e-04 | 284 | 29 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.18e-04 | 290 | 29 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 6.19e-04 | 27 | 29 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.21e-04 | 123 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.43e-04 | 293 | 29 | 4 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.85e-04 | 298 | 29 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | 7.06e-04 | 1143 | 29 | 7 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 7.17e-04 | 819 | 29 | 6 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.23e-04 | 141 | 29 | 3 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_200 | 9.26e-04 | 33 | 29 | 2 | gudmap_developingGonad_P2_epididymis_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.00e-03 | 330 | 29 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.04e-03 | 147 | 29 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.07e-03 | 336 | 29 | 4 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.07e-03 | 336 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.48e-03 | 166 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.50e-03 | 167 | 29 | 3 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.67e-03 | 379 | 29 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.69e-03 | 967 | 29 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | COL3A1 COL4A5 COLEC12 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL1A1 | 9.18e-16 | 159 | 30 | 9 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL1A1 | 4.46e-15 | 189 | 30 | 9 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL1A1 | 4.46e-15 | 189 | 30 | 9 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL18A1 COL6A2 COL5A3 COL6A3 COL1A1 | 4.46e-15 | 189 | 30 | 9 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 COL6A3 COL16A1 COL1A1 | 4.91e-15 | 191 | 30 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 COL6A3 COL16A1 COL1A1 | 5.14e-15 | 192 | 30 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 COL6A3 COL16A1 COL1A1 | 5.14e-15 | 192 | 30 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COLEC12 COL6A2 COL5A3 COL6A3 COL7A1 COL16A1 COL1A1 | 5.14e-15 | 192 | 30 | 9 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A4 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL16A1 COL1A1 | 6.50e-15 | 197 | 30 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A4 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL16A1 COL1A1 | 6.50e-15 | 197 | 30 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A5 COL5A1 COL6A2 COL5A3 COL6A3 COL11A2 COL16A1 COL1A1 | 6.81e-15 | 198 | 30 | 9 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A5 COL5A1 COL6A2 COL5A3 COL6A3 COL11A2 COL16A1 COL1A1 | 6.81e-15 | 198 | 30 | 9 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A1 COLEC12 COL6A2 COL6A3 COL22A1 COL11A2 COL16A1 COL1A1 | 6.81e-15 | 198 | 30 | 9 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COLEC12 COL6A2 COL6A3 COL22A1 COL11A2 COL16A1 COL1A1 | 7.46e-15 | 200 | 30 | 9 | 780d47f8eff630020dfae32218de495a7e9dbad6 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COLEC12 COL6A2 COL6A3 COL22A1 COL11A2 COL16A1 COL1A1 | 7.46e-15 | 200 | 30 | 9 | 28dd127787a57276253548d1f030814b1af64481 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-13 | 180 | 30 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-13 | 180 | 30 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-13 | 180 | 30 | 8 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-13 | 181 | 30 | 8 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-13 | 181 | 30 | 8 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-13 | 183 | 30 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-13 | 183 | 30 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-13 | 183 | 30 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.64e-13 | 184 | 30 | 8 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-13 | 185 | 30 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-13 | 185 | 30 | 8 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-13 | 185 | 30 | 8 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-13 | 186 | 30 | 8 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-13 | 188 | 30 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-13 | 188 | 30 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-13 | 190 | 30 | 8 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-13 | 190 | 30 | 8 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-13 | 190 | 30 | 8 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-13 | 191 | 30 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.92e-13 | 191 | 30 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.13e-13 | 192 | 30 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-13 | 192 | 30 | 8 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-13 | 192 | 30 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-13 | 193 | 30 | 8 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-13 | 193 | 30 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-13 | 194 | 30 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.58e-13 | 194 | 30 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-13 | 195 | 30 | 8 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-13 | 195 | 30 | 8 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-13 | 195 | 30 | 8 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-13 | 196 | 30 | 8 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-13 | 196 | 30 | 8 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-13 | 196 | 30 | 8 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-13 | 197 | 30 | 8 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.31e-13 | 197 | 30 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-13 | 197 | 30 | 8 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-13 | 198 | 30 | 8 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-13 | 198 | 30 | 8 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.57e-13 | 198 | 30 | 8 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-13 | 198 | 30 | 8 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-13 | 198 | 30 | 8 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-13 | 198 | 30 | 8 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-13 | 199 | 30 | 8 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-13 | 199 | 30 | 8 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 6.85e-13 | 199 | 30 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-13 | 199 | 30 | 8 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.85e-13 | 199 | 30 | 8 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-13 | 199 | 30 | 8 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.13e-13 | 200 | 30 | 8 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.13e-13 | 200 | 30 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.13e-13 | 200 | 30 | 8 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.13e-13 | 200 | 30 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-13 | 200 | 30 | 8 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.13e-13 | 200 | 30 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-13 | 200 | 30 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-13 | 200 | 30 | 8 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.13e-13 | 200 | 30 | 8 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.13e-13 | 200 | 30 | 8 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.41e-12 | 134 | 30 | 7 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.73e-12 | 153 | 30 | 7 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.73e-12 | 153 | 30 | 7 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.73e-12 | 153 | 30 | 7 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-11 | 159 | 30 | 7 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-11 | 159 | 30 | 7 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.43e-11 | 164 | 30 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.69e-11 | 168 | 30 | 7 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-11 | 169 | 30 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-11 | 169 | 30 | 7 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-11 | 170 | 30 | 7 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-11 | 171 | 30 | 7 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-11 | 176 | 30 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-11 | 176 | 30 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-11 | 180 | 30 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-11 | 182 | 30 | 7 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-11 | 182 | 30 | 7 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-11 | 184 | 30 | 7 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.21e-11 | 184 | 30 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 184 | 30 | 7 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-11 | 184 | 30 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-11 | 185 | 30 | 7 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| Computational | Adhesion molecules. | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL16A1 COL1A1 | 3.83e-12 | 141 | 22 | 9 | MODULE_122 |
| Computational | Neighborhood of CDH11 | 1.62e-07 | 25 | 22 | 4 | GNF2_CDH11 | |
| Computational | ECM and collagens. | 2.09e-07 | 225 | 22 | 7 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.85e-06 | 50 | 22 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.85e-06 | 50 | 22 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of PTX3 | 5.09e-05 | 36 | 22 | 3 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.37e-04 | 50 | 22 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Placenta genes. | 2.56e-04 | 463 | 22 | 6 | MODULE_38 | |
| Computational | Genes in the cancer module 105. | 6.54e-04 | 200 | 22 | 4 | MODULE_105 | |
| Computational | Spinal cord (neuro-development) genes. | 6.74e-04 | 360 | 22 | 5 | MODULE_12 | |
| Computational | Ovary genes. | 7.45e-04 | 368 | 22 | 5 | MODULE_1 | |
| Computational | Genes in the cancer module 55. | 9.85e-04 | 832 | 22 | 7 | MODULE_55 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 1.01e-03 | 835 | 22 | 7 | MODULE_88 | |
| Computational | Genes in the cancer module 153. | 2.16e-03 | 34 | 22 | 2 | MODULE_153 | |
| Computational | Genes in the cancer module 198. | 3.03e-03 | 303 | 22 | 4 | MODULE_198 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Drug | GK-101 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.51e-24 | 36 | 30 | 11 | CID000161853 |
| Drug | Madecassol | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 3.33e-23 | 46 | 30 | 11 | CID000108062 |
| Drug | AC1NMZ1B | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 DDX17 COL16A1 COL1A1 | 5.34e-23 | 75 | 30 | 12 | CID005034185 |
| Drug | strontium ranelate | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 RRS1 COL1A1 | 7.50e-23 | 77 | 30 | 12 | CID006918182 |
| Drug | d-indobufen | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 9.30e-23 | 50 | 30 | 11 | CID000044562 |
| Drug | ridogrel | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.50e-22 | 52 | 30 | 11 | CID005362391 |
| Drug | NSC49633 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.89e-22 | 53 | 30 | 11 | CID000023340 |
| Drug | AC1LAKND | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.25e-21 | 62 | 30 | 11 | CID000470146 |
| Drug | ticlopidine | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 RRS1 COL1A1 | 3.06e-21 | 103 | 30 | 12 | CID000005472 |
| Drug | BAPN | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 6.27e-21 | 71 | 30 | 11 | CID000001647 |
| Drug | malotilate | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 6.27e-21 | 71 | 30 | 11 | CID000004006 |
| Drug | halofuginone lactate | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 5.17e-20 | 85 | 30 | 11 | CID000062891 |
| Drug | DMSe | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL5A3 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 6.84e-20 | 132 | 30 | 12 | CID000020796 |
| Drug | 4-hydroxyproline | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.14e-19 | 91 | 30 | 11 | CID000000825 |
| Drug | PCR 4099 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 RRS1 COL1A1 | 1.30e-19 | 139 | 30 | 12 | CID000002806 |
| Drug | hydroxylysine | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 9.13e-19 | 109 | 30 | 11 | CID000001029 |
| Drug | AC1L1C2F | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.01e-18 | 110 | 30 | 11 | CID000001711 |
| Drug | PPACK | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.38e-18 | 113 | 30 | 11 | CID003036757 |
| Drug | AC1L9732 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.52e-18 | 114 | 30 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.68e-18 | 115 | 30 | 11 | CID000005527 |
| Drug | Selara | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 4.36e-18 | 125 | 30 | 11 | CID000150310 |
| Drug | pirfenidone | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.34e-17 | 138 | 30 | 11 | CID000040632 |
| Drug | DL-penicillamine | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.45e-17 | 139 | 30 | 11 | CID000004727 |
| Drug | candesartan cilexetil | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 2.34e-17 | 145 | 30 | 11 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 8.16e-17 | 162 | 30 | 11 | CID000072363 |
| Drug | khellin | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.50e-16 | 171 | 30 | 11 | CID000003828 |
| Drug | AC1L1DD6 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 2.50e-16 | 179 | 30 | 11 | CID000002299 |
| Drug | L-3,4-dehydroproline | COL3A1 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL16A1 COL1A1 | 2.91e-16 | 73 | 30 | 9 | CID000094284 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 4.58e-16 | 189 | 30 | 11 | CID000001413 |
| Drug | foscarnet | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 4.86e-16 | 190 | 30 | 11 | CID000003414 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 DMKN COL1A1 | 2.66e-15 | 314 | 30 | 12 | CID000447989 |
| Drug | AC1Q6PCP | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 4.06e-15 | 230 | 30 | 11 | CID000005267 |
| Drug | prostacyclin sodium salt | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.02e-14 | 250 | 30 | 11 | CID000000159 |
| Drug | hyaluronan | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.78e-14 | 263 | 30 | 11 | CID000024759 |
| Drug | losartan | COL3A1 COL4A5 COL5A1 COL18A1 SHE COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 2.44e-14 | 378 | 30 | 12 | CID000003961 |
| Drug | silibinin | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 4.31e-14 | 285 | 30 | 11 | CID000005213 |
| Drug | AC1L18QD | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.82e-13 | 325 | 30 | 11 | CID000000213 |
| Drug | AC1L1KMJ | COL3A1 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 3.74e-13 | 476 | 30 | 12 | CID000030956 |
| Drug | colchine | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 1.09e-12 | 383 | 30 | 11 | CID000002833 |
| Drug | chondroitin sulfate | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 2.46e-12 | 413 | 30 | 11 | CID000024766 |
| Drug | Y-27632 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 5.37e-12 | 444 | 30 | 11 | CID000005711 |
| Drug | AC1L9HPX | 2.63e-11 | 92 | 30 | 7 | CID000445279 | |
| Drug | aspirin | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 6.85e-11 | 563 | 30 | 11 | CID000002244 |
| Drug | 4-aminoazobenzene | 2.64e-10 | 66 | 30 | 6 | CID000006051 | |
| Drug | LMWH | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 3.88e-10 | 663 | 30 | 11 | CID000000772 |
| Drug | isodesmosine | 6.47e-10 | 33 | 30 | 5 | CID000013811 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 1.77e-09 | 90 | 30 | 6 | CID015942693 | |
| Drug | LS-63783 | COL3A1 COL4A5 COL5A1 COL18A1 COL6A2 COL6A3 COL7A1 COL22A1 COL11A2 COL16A1 COL1A1 | 2.94e-09 | 804 | 30 | 11 | CID000000231 |
| Drug | desmosine | 7.68e-09 | 53 | 30 | 5 | CID000025435 | |
| Drug | 1h00 | 1.02e-08 | 56 | 30 | 5 | CID000445950 | |
| Drug | 351A | 1.17e-08 | 20 | 30 | 4 | CID000122144 | |
| Drug | dermatan sulfate | 1.20e-08 | 220 | 30 | 7 | CID000032756 | |
| Drug | BPAT-143 | 4.12e-08 | 6 | 30 | 3 | CID000146249 | |
| Drug | Sirius red | 1.25e-07 | 35 | 30 | 4 | CID005486818 | |
| Drug | AC1MRIIV | 1.95e-07 | 39 | 30 | 4 | CID003518584 | |
| Drug | PD123177 | 2.92e-07 | 43 | 30 | 4 | CID000114899 | |
| Drug | NC-4 | 3.20e-07 | 44 | 30 | 4 | CID006420119 | |
| Drug | Rgd Peptide | 6.04e-07 | 239 | 30 | 6 | CID000104802 | |
| Drug | trapidil | 9.21e-07 | 57 | 30 | 4 | CID000005531 | |
| Drug | sodium chloride | COL3A1 COL4A5 COL5A1 COLEC12 COL18A1 COL6A2 COL6A3 COL7A1 COL1A1 | 1.10e-06 | 865 | 30 | 9 | CID000000206 |
| Drug | AC1Q641C | 1.30e-06 | 62 | 30 | 4 | CID000005005 | |
| Drug | calcium phosphate | 1.40e-06 | 149 | 30 | 5 | CID000024441 | |
| Drug | 8-azaguanine | 3.26e-06 | 78 | 30 | 4 | CID000008646 | |
| Drug | homocystine | 3.99e-06 | 82 | 30 | 4 | CID000010010 | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.62e-06 | 190 | 30 | 5 | 2619_UP | |
| Drug | dimethylnitrosamine | 5.37e-06 | 196 | 30 | 5 | CID000006124 | |
| Drug | pyrachlostrobin | 7.30e-06 | 811 | 30 | 8 | ctd:C513428 | |
| Drug | pyridinoline | 8.45e-06 | 99 | 30 | 4 | CID000105068 | |
| Drug | phenytoin | 9.21e-06 | 219 | 30 | 5 | CID000001775 | |
| Drug | Cytarabine | 1.00e-05 | 598 | 30 | 7 | ctd:D003561 | |
| Drug | Collagenase | 1.01e-05 | 4 | 30 | 2 | DB00048 | |
| Drug | ATFP | 1.01e-05 | 4 | 30 | 2 | CID000193783 | |
| Drug | haloperidol | 1.08e-05 | 394 | 30 | 6 | CID000003559 | |
| Drug | 17-isoprogesterone | COL3A1 COL4A5 COL5A1 COL7A1 COL11A2 COL16A1 CEBPG RRS1 COL1A1 | 1.30e-05 | 1170 | 30 | 9 | CID000004920 |
| Drug | B-Ms | 1.48e-05 | 114 | 30 | 4 | CID000445091 | |
| Drug | AC1L3XKP | 1.56e-05 | 37 | 30 | 3 | CID000123931 | |
| Drug | Saralasin | 1.67e-05 | 5 | 30 | 2 | ctd:D012504 | |
| Drug | carboxymethylcellulose | 1.69e-05 | 118 | 30 | 4 | CID000024748 | |
| Drug | 2,3-pentanedione | 2.40e-05 | 129 | 30 | 4 | ctd:C013186 | |
| Drug | Diphosphonates | 2.51e-05 | 6 | 30 | 2 | ctd:D004164 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 2.51e-05 | 6 | 30 | 2 | ctd:C502971 | |
| Drug | angiotensin | 3.11e-05 | 282 | 30 | 5 | CID003083715 | |
| Drug | Paclitaxel | 3.31e-05 | 720 | 30 | 7 | ctd:D017239 | |
| Drug | 4,4'-hexafluorisopropylidene diphenol | 3.50e-05 | 142 | 30 | 4 | ctd:C583074 | |
| Drug | ammonium perchlorate | 3.51e-05 | 7 | 30 | 2 | ctd:C053506 | |
| Drug | HHMD | 4.68e-05 | 8 | 30 | 2 | CID000171068 | |
| Drug | Pcme | 4.68e-05 | 8 | 30 | 2 | CID000169849 | |
| Drug | AC1OLRFQ | 4.68e-05 | 8 | 30 | 2 | CID007408461 | |
| Drug | Ambroxol | 6.01e-05 | 9 | 30 | 2 | ctd:D000551 | |
| Drug | azelastine | 6.01e-05 | 9 | 30 | 2 | ctd:C020976 | |
| Drug | Sialic acids | 6.47e-05 | 329 | 30 | 5 | CID000349960 | |
| Drug | Spurr resin | 8.15e-05 | 64 | 30 | 3 | CID006449895 | |
| Drug | enterotoxin C, staphylococcal | 9.16e-05 | 11 | 30 | 2 | ctd:C034959 | |
| Drug | rhamnose | 9.39e-05 | 356 | 30 | 5 | CID000000840 | |
| Drug | AC1NDXNT | 1.02e-04 | 69 | 30 | 3 | CID004633270 | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.06e-04 | 70 | 30 | 3 | ctd:C035208 | |
| Drug | 1-Naphthylisothiocyanate | 1.10e-04 | 871 | 30 | 7 | ctd:D015058 | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 6424_DN | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 2306_UP | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 3122_DN | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.77e-09 | 53 | 29 | 5 | C4707243 | |
| Disease | Ehlers-Danlos syndrome | 4.76e-08 | 8 | 29 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.80e-06 | 3 | 29 | 2 | C0220679 | |
| Disease | Alport syndrome | 2.80e-06 | 3 | 29 | 2 | cv:C1567741 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.80e-06 | 3 | 29 | 2 | C4552122 | |
| Disease | Collagen IV-related nephropathies | 2.80e-06 | 3 | 29 | 2 | cv:CN076135 | |
| Disease | Keloid | 5.47e-06 | 35 | 29 | 3 | C0022548 | |
| Disease | Bethlem myopathy | 5.59e-06 | 4 | 29 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 5.59e-06 | 4 | 29 | 2 | C1834674 | |
| Disease | Hematuria, Benign Familial | 5.59e-06 | 4 | 29 | 2 | C0241908 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 5.59e-06 | 4 | 29 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 5.59e-06 | 4 | 29 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 5.59e-06 | 4 | 29 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 5.59e-06 | 4 | 29 | 2 | cv:C4551860 | |
| Disease | Alport Syndrome | 5.59e-06 | 4 | 29 | 2 | C1567741 | |
| Disease | Ehlers-Danlos Syndrome | 9.31e-06 | 5 | 29 | 2 | C0013720 | |
| Disease | Alport Syndrome, X-Linked | 9.31e-06 | 5 | 29 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 9.31e-06 | 5 | 29 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 9.31e-06 | 5 | 29 | 2 | C1567744 | |
| Disease | myopathy (implicated_via_orthology) | 1.43e-05 | 48 | 29 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.95e-05 | 7 | 29 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.95e-05 | 7 | 29 | 2 | C1458140 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 3.34e-05 | 9 | 29 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 3.34e-05 | 9 | 29 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Nephrosclerosis | 5.10e-05 | 11 | 29 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 5.10e-05 | 11 | 29 | 2 | C0003504 | |
| Disease | collagen disease (implicated_via_orthology) | 6.12e-05 | 12 | 29 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 6.12e-05 | 12 | 29 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 9.06e-05 | 774 | 29 | 6 | C0023893 | |
| Disease | Blood Coagulation Disorders | 1.11e-04 | 16 | 29 | 2 | C0005779 | |
| Disease | Abortion, Tubal | 1.67e-04 | 109 | 29 | 3 | C0000822 | |
| Disease | Early Pregnancy Loss | 1.67e-04 | 109 | 29 | 3 | C3830362 | |
| Disease | Miscarriage | 1.67e-04 | 109 | 29 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.67e-04 | 109 | 29 | 3 | C0000786 | |
| Disease | central corneal thickness | 2.28e-04 | 309 | 29 | 4 | EFO_0005213 | |
| Disease | Renal glomerular disease | 2.33e-04 | 23 | 29 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.33e-04 | 23 | 29 | 2 | C4521256 | |
| Disease | Left Ventricular Hypertrophy | 2.76e-04 | 25 | 29 | 2 | C0149721 | |
| Disease | Heart valve disease | 2.99e-04 | 26 | 29 | 2 | C0018824 | |
| Disease | necrotizing enterocolitis | 3.22e-04 | 27 | 29 | 2 | EFO_0003928 | |
| Disease | Hereditary hearing loss and deafness | 3.95e-04 | 146 | 29 | 3 | cv:C0236038 | |
| Disease | Cholestasis, Extrahepatic | 4.54e-04 | 32 | 29 | 2 | C0005398 | |
| Disease | cervical cancer | 7.11e-04 | 40 | 29 | 2 | MONDO_0002974 | |
| Disease | end stage renal disease (is_implicated_in) | 7.47e-04 | 41 | 29 | 2 | DOID:783 (is_implicated_in) | |
| Disease | Microcalcification | 7.84e-04 | 42 | 29 | 2 | C0521174 | |
| Disease | Calcinosis | 7.84e-04 | 42 | 29 | 2 | C0006663 | |
| Disease | Tumoral calcinosis | 7.84e-04 | 42 | 29 | 2 | C0263628 | |
| Disease | corneal resistance factor | 9.45e-04 | 451 | 29 | 4 | EFO_0010067 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGGKGERGLPGPPGS | 336 | Q07092 | |
| SSGIPGKEGPGGKPG | 481 | Q07092 | |
| GKEGPGGKPGKPGVK | 486 | Q07092 | |
| KGKVGPPGGRGPKGE | 471 | P53420 | |
| PPGGRGPKGEKGNEG | 476 | P53420 | |
| PGKHGASGPPGNKGA | 541 | P53420 | |
| GGGKAGKGGPTPQEA | 11 | Q9H444 | |
| QCKAPKPDGPGGGPG | 446 | P35637 | |
| AGAPGHKGSKGAPGP | 976 | P39060 | |
| GFPGPAGPKGNLGSK | 1151 | P39060 | |
| GPPGERGGKGSKGSQ | 491 | Q5KU26 | |
| PAGPKGAKGATGPGG | 1466 | P13942 | |
| GLPGEGFPGPKGEKG | 401 | Q2UY09 | |
| PKGDRGGPGIPGFKG | 596 | Q2UY09 | |
| GGGNGHKPGCEKPGN | 321 | Q6E0U4 | |
| PPGLPGNGGIKGEKG | 1271 | P29400 | |
| GRRGPPGAKGNKGGP | 2201 | P12111 | |
| PGAKGNKGGPGQPGF | 2206 | P12111 | |
| RKGEPGEPGPKGGIG | 2271 | P12111 | |
| APGSPGVKGAKGGPG | 401 | P12110 | |
| GVKGAKGGPGPRGPK | 406 | P12110 | |
| GAAGAPGKGSEKGPP | 216 | O00257 | |
| GKEGPPGEKGGQGPP | 766 | P20908 | |
| PGANGEKGGRGTPGK | 891 | P20908 | |
| ITGKPGPKGNSGGDG | 926 | P20908 | |
| GDPGIKGDKGPPGGK | 1396 | Q8NFW1 | |
| KGDKGPPGGKGQPGD | 1401 | Q8NFW1 | |
| PKGDAGAPGAPGGKG | 661 | P02461 | |
| GAPGAPGGKGDAGAP | 666 | P02461 | |
| PGAKGEKGAPGGLAG | 2306 | Q02388 | |
| GGGGLPPKKFGNPGE | 101 | Q92841 | |
| GGGEKAKGGPPPGNA | 621 | Q9HBR0 | |
| PAGPGGGGKAVAPSK | 36 | P53567 | |
| KGDSGPSGAAGPPGK | 1231 | P25940 | |
| PGKPGAQGEPGPKGD | 166 | A6NHN0 | |
| GPPANGNGNGGGKGK | 11 | Q9ULQ0 | |
| KKGPGPGGGVSGGKA | 6 | O95081 | |
| GFPGPKGAAGEPGKA | 581 | P02452 | |
| GPPSQGGKRKGGLGG | 326 | Q15050 | |
| EPPGGGGSKGNKNGD | 656 | Q9UGU0 | |
| AGGAGPGPGKGRKNS | 71 | Q5VZ18 | |
| GSPKLGPGKGHQGFG | 456 | Q5T4S7 | |
| AAAGPGDPKRKGGPG | 96 | Q9BQ61 |